(44 days)
A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.
Classified by FDA's General and Plastic Surgery Device panel as Class I, 21 CFR 880.6250, Patient Examination Glove, 80LZA, and meets all requirements of ASTM Standard D6319-00aE3.
The provided text is a 510(k) summary for a medical device: "Syntex Powder-Free Nitrile Examination Glove, Tested for Chemotherapy." Based on the provided document, the device is a Class I patient examination glove. The document describes non-clinical tests to demonstrate substantial equivalence to a predicate device.
Here's an analysis of the acceptance criteria and study information provided in the document:
1. Table of Acceptance Criteria and Reported Device Performance
| Acceptance Criteria / Standard | Reported Device Performance |
|---|---|
| Physical and Dimensions Testing: | |
| ASTM-D-6319-00aE3 (General Glove Standard) | "All testing meets requirements for Physical and Dimensions Testing conducted on gloves, Inspection Level S-2, AOL 4.0." And "Syntex Healthcare Products Co., Ltd. Syntex Powder-Free Nitrile Examination Glove, Tested for Chemotherapy conform fully to ASTM-D-6319-00a€3 standard..." |
| Pinhole / Water Leak Test: | |
| FDA 1000 ml. Water Fill Test (AQL 2.5, Inspection Level G-1) | "The FDA 1000 ml. Water Fill Test was also conducted with samplings of AQL 2.5, Inspection Level G-1, meeting these requirements." And "...meets pinhole FDA requirements." |
| Biocompatibility (Skin Irritation/Sensitization): | |
| Primary Skin Irritation and Skin Sensitization testing | "Primary Skin irritation and Skin Sensitization (allergic contact dermatitis) testing was conducted with results showing no primary skin irritant or sensitization reactions." And "...biocompatibility requirements..." |
| Powder Residue (for "powder-free" claim): | |
| ASTM D6124-01 for Starch (no more than 2 mg powder per glove) | "A Residual Powder Test that based on ASTM D6124-01 for Starch at finished inspection is conducted to insure that our gloves meet our "powder-free' claims (contain no more than 2 mg powder per glove)." |
| Chemotherapy Permeation (Implied based on device name, but not explicitly detailed in the summary) | The device is named "Tested for Chemotherapy," implying specific testing for this use. However, the 510(k) summary does not explicitly detail the acceptance criteria or results for chemotherapy permeation testing. It only states that the device "conform[s] fully to ASTM-D-6319-00a€3 standard as well as applicable 21 CFR references, and, meets pinhole FDA requirements. biocompatibility requirements and labeling claims as shown by data in Section 7." The lack of specific details for chemotherapy testing in Section 7 (Discussion of Non-Clinical tests) and Section 8 (Discussion of Clinical Tests) is a notable omission in this summary regarding the "Tested for Chemotherapy" aspect. |
2. Sample Size Used for the Test Set and the Data Provenance
- Physical and Dimensions Testing: Inspection Level S-2, AQL 4.0. (This refers to a sampling plan for quality control rather than a specific sample size for a "test set" in an AI/Software context).
- FDA 1000 ml. Water Fill Test: AQL 2.5, Inspection Level G-1. (Again, a sampling plan for quality control).
- Biocompatibility (Skin Irritation/Sensitization), Residual Powder Test: No specific sample sizes are mentioned for these tests, only that testing was "conducted."
- Data Provenance: Not applicable in the context of this device (a physical glove). The tests are performed on manufactured gloves.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts
This information is not applicable to this type of device (a physical examination glove). Ground truth in this context is established by physical measurements and laboratory analyses against defined standards, not by expert interpretation of data.
4. Adjudication Method for the Test Set
This information is not applicable to this type of device. Adjudication methods are typically used in studies involving human interpretation or subjective assessment.
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
This information is not applicable to this type of device. An MRMC study is relevant for AI-powered diagnostic tools where human readers (e.g., radiologists) use the AI for assistance. This device is a physical glove.
6. If a Standalone (i.e. algorithm only without human-in-the loop performance) was done
This information is not applicable to this type of device. "Standalone performance" refers to the performance of an algorithm without human intervention, which is not relevant for a physical glove.
7. The Type of Ground Truth Used
The ground truth for this device's performance is based on defined physical and chemical standards as outlined in relevant ASTM standards and FDA requirements. This includes:
- Physical dimensions and tensile strength (ASTM-D-6319-00aE3)
- Barrier integrity (FDA 1000 ml. Water Fill Test for pinholes)
- Biocompatibility (Primary Skin irritation and Skin Sensitization testing via laboratory methods)
- Powder content (ASTM D6124-01)
- (Implied: Chemotherapy permeation data based on the device name, but methods/results are not detailed in this summary).
8. The Sample Size for the Training Set
This information is not applicable to this type of device. Training sets are relevant for machine learning algorithms, not for physical products like gloves.
9. How the Ground Truth for the Training Set was Established
This information is not applicable to this type of device, as it does not involve a training set for an algorithm.
{0}------------------------------------------------
510(K) SUMMARY
This summary of 510(k) safety and effectiveness information is being submitted in accordance with requirements of SMDA 1990 and 21 CFR §807.92.
The assigned 510(k) number is: _KO4 2226
1. Submitter's Identification:
Mr. Hao Jun Jie Syntex Healthcare Products Co., Ltd. No. 1 Fangjiazhuang Industrial Zone Xinji, Hebei Province P.R. China
Date Summary Prepared: July 01, 2004
2. Name of the Device:
Syntex Healthcare Products Co., Ltd.
Syntex Powder-Free Nitrile Examination Glove, Tested for Chemotherapy
3. Predicate Device Information:
Syntex Healthcare Products Co., Ltd.
Syntex Powder-Free Nitrile Examination Glove (K020493)
4. Device Description:
Classified by FDA's General and Plastic Surgery Device panel as Class I, 21 CFR 880.6250, Patient Examination Glove, 80LZA, and meets all requirements of ASTM Standard D6319-00aE3.
5. Intended Use:
A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.
{1}------------------------------------------------
6. Comparison to Predicate Devices:
Syntex Healthcare Products Co., Ltd. Syntex Powder-Free Nitrile Examination Glove, Tested for Chemotherapy is substantially equivalent in safety and effectiveness to the Syntex Healthcare Products Co., Ltd. Syntex Powder-Free Nitrile Examination Glove.
7. Discussion of Non-Clinical tests Performed for Determination of Substantial Equivalence are as follows:
The standards used for Syntex Healthcare Products Co., Ltd. glove production are based on ASTM-D-6319-00a€3. All testing meets requirements for Physical and Dimensions Testing conducted on gloves, Inspection Level S-2, AOL 4.0.
The FDA 1000 ml. Water Fill Test was also conducted with samplings of AQL 2.5, Inspection Level G-1, meeting these requirements. Primary Skin irritation and Skin Sensitization (allergic contact dermatitis) testing was conducted with results showing no primary skin irritant or sensitization reactions.
There are no special labeling claims and we do not claim our gloves as hypoallergenic on our labels.
A Residual Powder Test that based on ASTM D6124-01 for Starch at finished inspection is conducted to insure that our gloves meet our "powder-free' claims (contain no more than 2 mg powder per glove).
8. Discussion of Clinical Tests Performed:
Not Applicable - There is no hypoallergenic Claim.
9. Conclusions:
Syntex Healthcare Products Co., Ltd. Syntex Powder-Free Nitrile Examination Glove, Tested for Chemotherapy conform fully to ASTM-D-6319-00a€3 standard as well as applicable 21 CFR references, and, meets pinhole FDA requirements. biocompatibility requirements and labeling claims as shown by data in Section 7. There are no safety/efficacy issues or new claims from the "substantial equivalence" products cited.
{2}------------------------------------------------
Image /page/2/Picture/2 description: The image shows the seal of the Department of Health & Human Services (HHS). The seal features a stylized eagle with three parallel lines forming its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle. The seal is black and white.
SEP 3 0 2004
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Syntex Healthcare Products Company Limited C/O Mr. James Chu Official Correspondent Gloveco, Incorporated 590 West Central Avenue, #D Brea, California 92821
Re: K042226
Trade/Device Name: Syntex Powder-Free Nitrile Examination Glove, Tested for Use With Chemotherapy Drugs-Blue Regulation Number: 880.6250 Regulation Name: Patient Examination Glove Regulatory Class: I Product Code: LZA Dated: August 13, 2004 Received: August 17, 2004
Dear Mr. Chu:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
Page 2 - Mr. Chu
Please be advised that FDA's issuance of a substantial equivalence determination does not I lease of advisod that 122 a determination that your device complies with other requirements Incall that I Dri has made statutes and regulations administered by other Federal agencies. of the Act of ally I ederal based a requirements, including, but not limited to: registration 1 ou intiles compry wart 807); labeling (21 CFR Part 801); good manufacturing practice allo listing (21 CFR Part 807), as ality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) I mis letter will anow yourse of substantial equivalence of your device to a premarketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), If you desire specific af Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the may overn Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Chiao Liu, Ph.D.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Attachment A
INDICATIONS FOR USE
510(k) NUMBER' (IF KNOWN) : APPLICANT: DEVICE NAME:
K042226 Syntex Healthcare Products Co., Ltd. Syntex Powder-Free Nitrile Examination Glove, Tested for USE WHO Chemotherapy DRUGS - BLUE
INDICATIONS FOR USE:
A patient examination glove is disposable device intended for medical purpose that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.
Prescription Use (Per 21 CFR 801.109) OR
Over-The-Counter-Use
(Optional Format 1-2-96)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED.)
Concurrent of CDRH, Office of Device Evaluation (ODE)
| (Division Sign-Off) | |
|---|---|
| Division of Anesthesiology, General Hospital, Infection Control, Dental Devices | |
| 510(k) Number: | K042226 |
§ 880.6250 Non-powdered patient examination glove.
(a)
Identification. A non-powdered patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. A non-powdered patient examination glove does not incorporate powder for purposes other than manufacturing. The final finished glove includes only residual powder from manufacturing.(b)
Classification. Class I (general controls). The device, when it is a finger cot, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 880.9.